{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:23:34Z","timestamp":1778711014058,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":843,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001599","name":"National Council for Forest Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.yexmp.2010.12.007","type":"journal-article","created":{"date-parts":[[2010,12,30]],"date-time":"2010-12-30T07:08:27Z","timestamp":1293692907000},"page":"189-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Absence of galectin-3 does not affect the development of experimental tongue carcinomas in mice"],"prefix":"10.1016","volume":"90","author":[{"given":"Paulo Rog\u00e9rio","family":"de Faria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Chammas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaissa Lopes","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel K.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suely","family":"Nonogaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgio Vitorino","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano Mota","family":"Loyola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2010.12.007_bb0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00432-007-0345-3","article-title":"Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study","volume":"134","author":"Abdel-Aziz","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0010","first-page":"261","article-title":"Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality","volume":"123","author":"Betka","year":"2003","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0015","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<776::AID-CNCR17>3.0.CO;2-Q","article-title":"Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system","volume":"80","author":"Bresalier","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.yexmp.2010.12.007_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.pgp.0000179613.40215.c0","article-title":"Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions","volume":"25","author":"Brustmann","year":"2006","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO;2-N","article-title":"Decreased expression of galectin-3 is associated with progression of human breast cancer","volume":"179","author":"Castronovo","year":"1996","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0030","first-page":"210","article-title":"Galectin-3 and proliferating cell nuclear antigen (PCNA) expression in papillary thyroid carcinoma","volume":"27","author":"Cvejic","year":"2005","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0035","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexmp.2010.12.007_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/glycob\/cwn105","article-title":"Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice","volume":"19","author":"Eude-Le Parco","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.yexmp.2010.12.007_bb0045","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/(SICI)1097-0347(199609\/10)18:5<422::AID-HED5>3.0.CO;2-7","article-title":"Expression of galectins in head and neck squamous cell carcinoma","volume":"18","author":"Gillenwater","year":"1996","journal-title":"Head Neck"},{"key":"10.1016\/j.yexmp.2010.12.007_bb0050","first-page":"4635","article-title":"Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma","volume":"6","author":"Honjo","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0055","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0002-9440(10)64975-9","article-title":"Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses","volume":"156","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s004320000207","article-title":"Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures","volume":"127","author":"Lahm","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00432-005-0069-1","article-title":"Decreased galectin-3 expression during the progression of cervical neoplasia","volume":"132","author":"Lee","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrc1527","article-title":"Galectins as modulators of tumour progression","volume":"5","author":"Liu","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2010.12.007_bb0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1079-2104(05)80226-4","article-title":"Oral epithelial dysplasia and the development of invasive squamous cell carcinoma","volume":"79","author":"Lumerman","year":"1995","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0080","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/modpathol.3800416","article-title":"Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung","volume":"18","author":"Mathieu","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0085","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1200\/JCO.2002.01.078","article-title":"Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma","volume":"20","author":"Piantelli","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0090","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.ejca.2004.06.025","article-title":"Galectin-3 \u2014 an emerging prognostic indicator in advanced head and neck carcinoma","volume":"40","author":"Plz\u00e1k","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexmp.2010.12.007_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2004.03.006","article-title":"Galectin-3 expression in non-small cell lung carcinoma","volume":"212","author":"Puglisi","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0100","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/MLG.0b013e31817b0718","article-title":"Galectin-3 upregulation during tumor progression in head and neck cancer","volume":"118","author":"Saussez","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.yexmp.2010.12.007_bb0105","first-page":"235","article-title":"Impact of nuclear galectin-3 expression on histological differentiation and vascular invasion in patients with esophageal squamous cell carcinoma","volume":"13","author":"Shibata","year":"2005","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0115","series-title":"World Health Organization Classification of Tumors","first-page":"118","article-title":"Tumors of the hypopharynx, larynx and trachea","author":"Slootweg","year":"2005"},{"key":"10.1016\/j.yexmp.2010.12.007_bb0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3835(03)00056-9","article-title":"Malignant transformation of thyroid follicular cells by galectin-3","volume":"195","author":"Takenaka","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1078-0432.CCR-0999-3","article-title":"Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice","volume":"10","author":"Tang","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.oraloncology.2007.08.015","article-title":"The hamster model of sequential oral oncogenesis","volume":"44","author":"Vairaktaris","year":"2008","journal-title":"Oral Oncol."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0135","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1023\/B:GLYC.0000014083.48508.6a","article-title":"Expression of galectins in cancer: a critical review","volume":"19","author":"van den Br\u00fble","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00403-004-0536-6","article-title":"Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors","volume":"296","author":"Vereecken","year":"2005","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.yexmp.2010.12.007_bb0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archotol.133.5.503","article-title":"Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin\/Wnt-pathway activation in thyroid carcinoma","volume":"133","author":"Weinberger","year":"2007","journal-title":"Arch. Otolaryngol. Head Neck Surg."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480010001796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480010001796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:37:10Z","timestamp":1757990230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480010001796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0014480010001796"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2010.12.007","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absence of galectin-3 does not affect the development of experimental tongue carcinomas in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2010.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}